Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
0.990
-0.120 (-10.81%)
Dec 20, 2024, 4:00 PM EST - Market closed
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $25.67 million as of December 20, 2024. Its market cap has decreased by -53.41% in one year.
Market Cap
25.67M
Enterprise Value
24.27M
1-Year Change
-53.41%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $25.67M, a decrease of -84.24%. That is a compound annual growth rate of -39.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 25.67M | -58.61% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 26.27M |
| Cognition Therapeutics | 26.18M |
| Curis | 26.08M |
| Lipocine | 26.04M |
| AEON Biopharma | 25.98M |
| BriaCell Therapeutics | 25.53M |
| Femasys | 24.96M |
| Longeveron | 24.48M |